
Reset all filters
01 3Baqsimi
02 3Glucagon
Main Therapeutic Indication : Diabetes
Currency : USD
2023 Revenue in Millions : 678
2022 Revenue in Millions : 139
Growth (%) : 386
Main Therapeutic Indication : Diabetes
Currency : USD
2024 Revenue in Millions : 29
2023 Revenue in Millions : 678
Growth (%) : -96
Main Therapeutic Indication : Diabetes
Currency : USD
2015 Revenue in Millions : 105
2014 Revenue in Millions : 121
Growth (%) : 15%
Main Therapeutic Indication : Diabetes
Currency : USD
2016 Revenue in Millions : 133
2015 Revenue in Millions : 121
Growth (%) : 10
Main Therapeutic Indication : Diabetes
Currency : USD
2019 Revenue in Millions : 22
2018 Revenue in Millions : 0
Growth (%) : New launch
Main Therapeutic Indication : Diabetes
Currency : USD
2019 Revenue in Millions : 133
2018 Revenue in Millions : 149
Growth (%) : -11